Patents by Inventor Elizabeth J. Kelly

Elizabeth J. Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210130414
    Abstract: This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided.
    Type: Application
    Filed: January 11, 2021
    Publication date: May 6, 2021
    Inventors: Stephen James Russell, Elizabeth J. Kelly, Elizabeth M. Hadac
  • Patent number: 10913775
    Abstract: This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: February 9, 2021
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Elizabeth J. Kelly, Elizabeth M. Hadac
  • Publication number: 20180215794
    Abstract: This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided.
    Type: Application
    Filed: March 27, 2018
    Publication date: August 2, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Elizabeth J. Kelly, Elizabeth M. Hadac
  • Patent number: 9957302
    Abstract: This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: May 1, 2018
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Elizabeth J. Kelly, Elizabeth M. Hadac
  • Publication number: 20150299271
    Abstract: This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided.
    Type: Application
    Filed: July 6, 2015
    Publication date: October 22, 2015
    Inventors: Stephen James Russell, Elizabeth J. Kelly, Elizabeth M. Hadac
  • Publication number: 20130345414
    Abstract: This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided.
    Type: Application
    Filed: July 26, 2013
    Publication date: December 26, 2013
    Inventors: Stephen James Russell, Elizabeth J. Kelly, Elizabeth M. Hadac
  • Publication number: 20100111873
    Abstract: This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided.
    Type: Application
    Filed: February 20, 2008
    Publication date: May 6, 2010
    Inventors: Stephen J. Russell, Elizabeth J. Kelly, Elizabeth M. Hadac